Off‐label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice

Authors

Institutions

Publication Details

Journal
Pediatric Allergy and Immunology
Published
2025-02-01
DOI
https://doi.org/10.1111/pai.70049
Citations
1
Primary Topic
Urticaria and Related Conditions
Type
article
Field-Weighted Citation Impact
1.67

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Off‐label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice

Lin Ma, Xing Huan, Shan Wang, Ying Liu et al.
1 citations
Pediatric Allergy and Immunology
Urticaria and Related Conditions
1.67
article

Off‐label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice

Lin Ma, Xing Huan, Shan Wang, Ying Liu, Bin Zhang, Qiong Wu
article en
1 citations

Abstract

No abstract available for this paper.
Pediatric Allergy and ImmunologyVol. 36(2)
Capital Medical University (CN), Beijing Children’s Hospital (CN)
National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, National Key Research and Development Program of China
Zero hunger
Openalex Percentile: Top 20%
Urticaria and Related Conditions
1.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.